CoChat

Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community

Open access
Chalmers, Jane, Wilkes, Emilie, Harris, Rebecca, Kent, Lucy, Kinra, Sonali, Aithal, Guru, Holmes, Mary, Johnson, Jeanette, Morling, Joanne, Guha, Indra Neil · 2020 · Frontline Gastroenterology
Cited by 68

The DOI matches its Crossref record.

Abstract

Objective: To describe the development of the Nottingham liver disease stratification pathway, present a 12-month evaluation of uptake and stratification results, and compare the pathway with current British Society of Gastroenterology (BSG) guidelines. Design: A referral pathway between primary and secondary care for the detection and risk stratification of liver disease. Setting: Four Nottinghamshire clinical commissioning groups (700 000 population). Patients: Patients are referred to the pathway with (1) raised aspartate aminotransferase to alanine aminotransferase (AST:ALT) ratio, (2) harmful alcohol use or (3) risk or presence of non-alcoholic fatty liver disease (NAFLD). Interventions: We report on clinic attendance within secondary care for transient elastography (TE) and brief lifestyle intervention. The TE result is reported back to the general practitioner with advice on interpretation and referral guidance. Main outcome measures: Pathway uptake, patient characteristics, liver disease stratification results and stakeholder feedback. Results: Over the first 12 months 968 patients attended a TE clinic appointment, with raised AST:ALT ratio being the most common single reason for referral (36.9%). Of the total, 222 (22.9%) patients had an elevated liver stiffness (≥8 kPa), in whom 57 (25.7%) had a liver stiffness which was indicative of advanced chronic liver disease. If a traditional approach based on raised liver enzymes (BSG guidance) had been followed, 38.7% of those with significant liver disease (≥8 kPa) would have gone undetected among those referred for either NAFLD or raised AST:ALT ratio. Conclusions: Targeting patients with risk factors for chronic liver disease and stratifying them using TE can detect significant chronic liver disease above and beyond the approach based on liver enzyme elevation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/flgastro-2019-101177

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 68

Metadata

Authors
Chalmers, J., Wilkes, E., Harris, R., Kent, L., Kinra, S., Aithal, G., Holmes, M., Johnson, J., Morling, J., & Guha, I. N.
Venue
Frontline Gastroenterology
Publisher
BMJ
Published
2019-06-26
Volume
11
Issue
2
Pages
86-92
ISSN
  • 2041-4137 (ISSN-L)
  • 2041-4145
OpenAlex
W2954383828
Cited by
68
References
0
FWCI
5.46
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community. https://app.cochat.ai/papers/10.1136/flgastro-2019-101177
The paper
Chalmers, J., Wilkes, E., Harris, R., Kent, L., Kinra, S., Aithal, G., Holmes, M., Johnson, J., Morling, J., & Guha, I. N. (2020). Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community. Frontline Gastroenterology. https://doi.org/10.1136/flgastro-2019-101177

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.